Biostem Technologies Inc (BSEM) is a biotechnology company listed on US.
Latest reported BSEM revenue for 2026-06-30 was $14.0M. Net income was -$17.8M. Revenue was down 47.9% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M and trailing P/E 8.5.
Use this BSEM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BSEM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BSEM SEC filings page. Lician reads the product cache first so this HTML stays unique to Biostem Technologies Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BSEM income, balance, and cash tables.